SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment response
{{output}}
Objective: This study was undertaken to evaluate whether synaptic vesicle protein 2A (SV2A) expression on peripheral immune cells predicts treatment response to levetiracetam in epilepsy. ... ...
